{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:37Z","timestamp":1792176457836,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bioorg.2024.107605","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T22:22:32Z","timestamp":1719699752000},"page":"107605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Recent advances in small molecule Nav 1.7 inhibitors for cancer pain management"],"prefix":"10.1016","volume":"150","author":[{"given":"Xiaoquan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoguan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bioorg.2024.107605_b0005","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/hmg\/ddm160","article-title":"A stop codon mutation in SCN9A causes lack of pain sensation","volume":"16","author":"Ahmad","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107605_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1399-0004.2007.00790.x","article-title":"Loss-of-function mutations in the Nav1. 7 gene underlie congenital indifference to pain in multiple human populations","volume":"71","author":"Goldberg","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bioorg.2024.107605_b0015","doi-asserted-by":"crossref","unstructured":"King GF, Vetter I: No gain, no pain: NaV1. 7 as an analgesic target. ACS chemical neuroscience 2014, 5(9):749-751.","DOI":"10.1021\/cn500171p"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/13543784.2016.1121992","article-title":"Novel sodium channel antagonists in the treatment of neuropathic pain","volume":"25","author":"Rivara","year":"2016","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107605_b0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn3404","article-title":"The NaV1. 7 sodium channel: from molecule to man","volume":"14","author":"Dib-Hajj","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107605_b0030","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/brain\/aws225","article-title":"Neurological perspectives on voltage-gated sodium channels","volume":"135","author":"Eijkelkamp","year":"2012","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107605_b0035","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4155\/fmc.10.26","article-title":"Isoform-selective voltage-gated Na+ channel modulators as next-generation analgesics","volume":"2","author":"England","year":"2010","journal-title":"Future Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2024.107605_b0040","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications","volume":"58","author":"de Lera","year":"2015","journal-title":"J. Med. Chem."},{"issue":"48","key":"10.1016\/j.bioorg.2024.107605_b0045","doi-asserted-by":"crossref","first-page":"12566","DOI":"10.1523\/JNEUROSCI.3424-06.2006","article-title":"Na<sub>v<\/sub>1.7 Mutant A863P in Erythromelalgia: Effects of Altered Activation and Steady-State Inactivation on Excitability of Nociceptive Dorsal Root Ganglion Neurons","volume":"26","author":"Harty","year":"2006","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.bioorg.2024.107605_b0050","doi-asserted-by":"crossref","first-page":"13126","DOI":"10.1073\/pnas.97.24.13126","article-title":"Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells","volume":"97","author":"Raraty","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107605_b0055","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1073\/pnas.94.4.1527","article-title":"Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons","volume":"94","author":"Toledo-Aral","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bph.12634","article-title":"Analgesic efficacy of opioids in chronic pain: recent meta-analyses","volume":"172","author":"Reinecke","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107605_b0065","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1113\/jphysiol.2011.224204","article-title":"Voltage-gated sodium channels at 60: structure, function and pathophysiology","volume":"590","author":"Catterall","year":"2012","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuron.2013.09.012","article-title":"Noncanonical roles of voltage-gated sodium channels","volume":"80","author":"Black","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bioorg.2024.107605_b0075","article-title":"Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy","volume":"8:1744\u20138069-1748-1717","author":"Chattopadhyay","year":"2012","journal-title":"Mol. Pain"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1526-4637.2011.01300.x","article-title":"The effects of coexisting fibromyalgia syndrome on pain intensity, disability, and treatment outcome in patients with chronic lateral epicondylitis","volume":"13","author":"Genc","year":"2012","journal-title":"Pain Med."},{"issue":"7342","key":"10.1016\/j.bioorg.2024.107605_b0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature09975","article-title":"Loss-of-function mutations in sodium channel Nav1. 7 cause anosmia","volume":"472","author":"Weiss","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pestbp.2009.06.010","article-title":"State-dependent modification of voltage-gated sodium channels by pyrethroids","volume":"97","author":"Soderlund","year":"2010","journal-title":"Pestic. Biochem. Physiol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107605_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrn2834","article-title":"Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease","volume":"11","author":"L\u00fcscher","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107605_b0105","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1113\/jphysiol.2003.047357","article-title":"Distinct repriming and closed-state inactivation kinetics of Nav1. 6 and Nav1. 7 sodium channels in mouse spinal sensory neurons","volume":"551","author":"Herzog","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.bioorg.2024.107605_b0110","doi-asserted-by":"crossref","unstructured":"Storer RI, Pike A, Swain NA, Alexandrou AJ, Bechle BM, Blakemore DC, Brown AD, Castle NA, Corbett MS, Flanagan NJ: Highly potent and selective NaV1. 7 inhibitors for use as intravenous agents and chemical probes. Bioorganic & Medicinal Chemistry Letters 2017, 27(21):4805-4811 %@ 0960-4894X.","DOI":"10.1016\/j.bmcl.2017.09.056"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107605_b0115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1039\/D2MD00081D","article-title":"Inhibition of Na V 1.7: the possibility of ideal analgesics","volume":"13","author":"Kitano","year":"2022","journal-title":"RSC Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107605_b0120","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1111\/bph.13092","article-title":"A novel selective and orally bioavailable N av 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability","volume":"172","author":"Payne","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107605_b0125","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.drudis.2019.05.014","article-title":"Voltage-gated sodium channels: structures, functions, and molecular modeling","volume":"24","author":"Xu","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107605_b0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/brain.2014.0274","article-title":"Fibromyalgia is associated with decreased connectivity between pain-and sensorimotor brain areas","volume":"4","author":"Flodin","year":"2014","journal-title":"Brain Connect."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107605_b0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107605_b0140","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.bmcl.2014.06.038","article-title":"Recent progress in sodium channel modulators for pain","volume":"24","author":"Bagal","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107605_b0150","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1073\/pnas.1324189111","article-title":"A disulfide tether stabilizes the block of sodium channels by the conotoxin \u03bcO \u00a7 -GVIIJ","volume":"111","author":"Gajewiak","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2024.107605_b0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2014.01.042","article-title":"Morphine inhibits acid-sensing ion channel currents in rat dorsal root ganglion neurons","volume":"1554","author":"Cai","year":"2014","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107605_b0160","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.3390\/md11124698","article-title":"Shellfish toxins targeting voltage-gated sodium channels","volume":"11","author":"Zhang","year":"2013","journal-title":"Mar. Drugs"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107605_b0165","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI92373","article-title":"Sodium channel Na V 1.9 mutations associated with insensitivity to pain dampen neuronal excitability","volume":"127","author":"Huang","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107605_b0170","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1021\/acs.jmedchem.7b00598","article-title":"Discovery of clinical candidate 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1, 3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of NaV1. 7","volume":"60","author":"Swain","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107605_b0175","article-title":"MicroRNA-182 alleviates neuropathic pain by regulating Nav1. 7 following spared nerve injury in rats","volume":"8(1):16750","author":"Cai","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107605_b0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/19336950.2020.1732003","article-title":"Activating Sirt1 by resveratrol suppresses Nav1. 7 expression in DRG through miR-182 and alleviates neuropathic pain in rats","volume":"14","author":"Jia","year":"2020","journal-title":"Channels"},{"key":"10.1016\/j.bioorg.2024.107605_b0185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/JPR.S185873","article-title":"Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K\/Akt and SIRT1\/PGC1\u03b1 pathway","author":"Li","year":"2019","journal-title":"J. Pain Res."},{"key":"10.1016\/j.bioorg.2024.107605_b0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.intimp.2016.02.033","article-title":"Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice","volume":"34","author":"Tao","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107605_b0195","first-page":"7152","article-title":"Intrathecal SRT1720, a SIRT1 agonist, exerts anti-hyperalgesic and anti-inflammatory effects on chronic constriction injury-induced neuropathic pain in rats","volume":"8","author":"Lv","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"26","key":"10.1016\/j.bioorg.2024.107605_b0200","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1097\/BRS.0b013e3181b8db15","article-title":"Direct single injection of p38 mitogen-activated protein kinase inhibitor does not affect calcitonin gene-related peptide expression in dorsal root ganglion neurons innervating punctured discs in rats","volume":"34","author":"Hayashi","year":"2009","journal-title":"Spine"},{"key":"10.1016\/j.bioorg.2024.107605_b0205","doi-asserted-by":"crossref","unstructured":"Sadamasu A, Sakuma Y, Suzuki M, Orita S, Yamauchi K, Inoue G, Aoki Y, Ishikawa T, Miyagi M, Kamoda H: Upregulation of NaV1. 7 in dorsal root ganglia after intervertebral disc injury in rats. Spine 2014, 39(7):E421-E426.","DOI":"10.1097\/BRS.0000000000000229"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107605_b0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1995-7645(14)60352-7","article-title":"Effect of down\u2014regulation of voltage\u2014gated sodium channel Nav1. 7 on activation of astrocytes and microglia in DRG in rats with cancer pain","volume":"8","author":"Pan","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107605_b0215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4239\/wjd.v6.i3.432","article-title":"Diabetic neuropathic pain: physiopathology and treatment","volume":"6","author":"Schreiber","year":"2015","journal-title":"World J. Diabetes"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107605_b0220","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1523\/JNEUROSCI.4872-09.2010","article-title":"ERK1\/2 mitogen-activated protein kinase phosphorylates sodium channel Nav1. 7 and alters its gating properties","volume":"30","author":"Stamboulian","year":"2010","journal-title":"J. Neurosci."},{"issue":"26","key":"10.1016\/j.bioorg.2024.107605_b0225","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1523\/JNEUROSCI.5530-07.2008","article-title":"Continuous \u03b4-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1. 7) levels through activation of protein kinase C in painful diabetic neuropathy","volume":"28","author":"Chattopadhyay","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107605_b0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuint.2014.05.012","article-title":"The role of TNF-alpha\/NF-kappa B pathway on the up-regulation of voltage-gated sodium channel Nav1. 7 in DRG neurons of rats with diabetic neuropathy","volume":"75","author":"Huang","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2024.107605_b0235","doi-asserted-by":"crossref","unstructured":"Sun J, Li N, Duan G, Liu Y, Guo S, Wang C, Zhu C, Zhang X: Increased Nav1. 7 expression in the dorsal root ganglion contributes to pain hypersensitivity after plantar incision in rats. Molecular Pain 2018, 14:1744806918782323.","DOI":"10.1177\/1744806918782323"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0240","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuroscience.2009.08.037","article-title":"Siqueira JTTd: Abnormal expression of voltage-gated sodium channels Nav1. 7, Nav1. 3 and Nav1. 8 in trigeminal neuralgia","volume":"164","author":"Siqueira","year":"2009","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107605_b0245","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1152\/jn.00763.2013","article-title":"Dynamic-clamp analysis of wild-type human Nav1. 7 and erythromelalgia mutant channel L858H","volume":"111","author":"Vasylyev","year":"2014","journal-title":"J. Neurophysiol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107605_b0250","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107605_b0255","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/practneurol-2013-000758","article-title":"The clinical approach to small fibre neuropathy and painful channelopathy","volume":"14","author":"Themistocleous","year":"2014","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.bioorg.2024.107605_b0260","doi-asserted-by":"crossref","unstructured":"Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, Estacion M, Lauria G, Vanhoutte EK, Gerrits MM: Gain of function Nav1. 7 mutations in idiopathic small fiber neuropathy. Annals of neurology 2012, 71(1):26-39.","DOI":"10.1002\/ana.22485"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107605_b0265","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.biocel.2006.12.004","article-title":"Epsin: inducing membrane curvature","volume":"39","author":"Horvath","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107605_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2006.121483","article-title":"Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons","volume":"579","author":"Rush","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.bioorg.2024.107605_b0275","article-title":"Roles of voltage-gated tetrodotoxin-sensitive sodium channels NaV1. 3 and NaV1. 7 in diabetes and painful diabetic neuropathy","volume":"17(9):1479","author":"Yang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107605_b0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresrev.2008.12.005","article-title":"Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment","volume":"60","author":"Dib-Hajj","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107605_b0285","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1523\/JNEUROSCI.4531-08.2009","article-title":"Regulation of persistent Na current by interactions between \u03b2 subunits of voltage-gated Na channels","volume":"29","author":"Aman","year":"2009","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0290","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/jpet.108.139410","article-title":"Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy","volume":"326","author":"Bordet","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107605_b0295","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bmcl.2018.12.013","article-title":"Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors","volume":"29","author":"Wu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107605_b0300","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1021\/acs.jmedchem.9b00202","article-title":"Correction to Discovery of Indole-and Indazole-acylsulfonamides as Potent and Selective NaV1. 7 Inhibitors for the Treatment of Pain","volume":"62","author":"Luo","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107605_b0305","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/acs.jmedchem.8b01621","article-title":"Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity","volume":"62","author":"Sun","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107605_b0310","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.bmcl.2018.04.035","article-title":"1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of Na V 1.7 inhibition","volume":"28","author":"Boezio","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.bioorg.2024.107605_b0315","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1021\/acs.jmedchem.6b00425","article-title":"Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors","volume":"59","author":"DiMauro","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107605_b0320","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1021\/acs.jmedchem.7b01826","article-title":"Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain","volume":"61","author":"Focken","year":"2018","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107605_b0325","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1021\/acs.jmedchem.1c00049","article-title":"Discovery of Acyl-sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310","volume":"64","author":"Safina","year":"2021","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107605_b0330","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/acsmedchemlett.3c00079","article-title":"N-Aryl Indoles as a Novel Class of Potent NaV1. 7 Inhibitors","volume":"14","author":"Karanjule","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107605_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117290","article-title":"Design, synthesis, and biological evaluation of acyl sulfonamide derivatives with spiro cycles as NaV1.7 inhibitors for antinociception","volume":"86","author":"Ouyang","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2024.107605_b0340","doi-asserted-by":"crossref","first-page":"10204","DOI":"10.1021\/acs.jmedchem.0c00259","article-title":"Discovery of DS-1971a, a Potent, Selective NaV1.7 Inhibitor","volume":"63","author":"Shinozuka","year":"2020","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107605_b0345","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1021\/acs.jmedchem.6b01850","article-title":"Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity","volume":"60","author":"Graceffa","year":"2017","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107605_b0350","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1021\/acs.jmedchem.6b01851","article-title":"Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities","volume":"60","author":"Weiss","year":"2017","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107605_b0355","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1021\/acs.jmedchem.9b00141","article-title":"Hackos DH et al.: Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain","volume":"62","author":"McKerrall","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107605_b0360","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1021\/acs.jmedchem.6b01918","article-title":"Development of new benzenesulfonamides as potent and selective Nav1. 7 inhibitors for the treatment of pain","volume":"60","author":"Wu","year":"2017","journal-title":"J. Med. Chem."},{"issue":"128892","key":"10.1016\/j.bioorg.2024.107605_b0365","article-title":"Discovery of pyridyl urea sulfonamide inhibitors of NaV1. 7","volume":"73","author":"Butler","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107605_b0370","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1021\/acs.jmedchem.0c00361","article-title":"Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides","volume":"63","author":"Ramdas","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107605_b0375","doi-asserted-by":"crossref","unstructured":"Patel MV, Peltier HM, Matulenko MA, Koenig JR, Scanio MJ, Gum RJ, El-Kouhen OF, Fricano MM, Lundgaard GL, Neelands T: Discovery of (R)-(3-fluoropyrrolidin-1-yl)(6-((5-(trifluoromethyl) pyridin-2-yl) oxy) quinolin-2-yl) methanone (ABBV-318) and analogs as small molecule Nav1. 7\/Nav1. 8 blockers for the treatment of pain. Bioorganic & Medicinal Chemistry 2022, 63:116743.","DOI":"10.1016\/j.bmc.2022.116743"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107605_b0380","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acsmedchemlett.2c00378","article-title":"Discovery of Selective Inhibitors of NaV1. 7 Templated on Saxitoxin as Therapeutics for Pain","volume":"13","author":"Pajouhesh","year":"2022","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824005108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824005108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:08:11Z","timestamp":1721207291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824005108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":76,"alternative-id":["S0045206824005108"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107605","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in small molecule Nav 1.7 inhibitors for cancer pain management","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107605"}}